NA Proactive news snapshot: CytoDyn, Nano One Materials, Marrone Bio, Newgioco …

CytoDyn Inc (OTCQB:CYDY), a late-stage biotechnology company, revealed Tuesday that it is collaborating with the UK’s Department of Health to provide emergency access to leronlimab (PRO 140), the company’s investigational drug for treating coronavirus (COVID-19) patients. The submission to the Medicines and Healthcare Products Regulatory Agency (MHRA), an executive agency of the UK government, sponsored by the Department of Health and Social Care, is expected to be made soon to include clinical trial sites in the United Kingdom. Nano One Materials Corp (CVE:NNO) (OTCMKTS:NNOMF) revealed the Canadian government has increased its contribution via a one-time payment to the tech business in response to the unprecedented coronavirus crisis. Sustainable Development Technology Canada (SDTC) has increased its contribution to Nano One's 'Scaling of Advanced Battery Materials' project by $250,000, bringing the total contribution to $5.25 million, the firm told investors in a statement on Tuesday. Capstone Turbine Corporation (NASDAQ:CPST), the maker of clean energy microturbines, said it has secured its third direct sales order.  In a statement Tuesday, the company said the order consists of six C65 microturbines from an industrial manufacturer of sorbent minerals in California. The order brings the current direct sales results to about $2.5 million, or 27% of last quarter’s $9.1 million in gross new product orders. Marrone Bio Innovations Inc (NASDAQ:MBII) announced Tuesday that Pacesetter, its recently approved bio-based plant health product, is now available to corn, soybean and wheat growers in the US. Pacesetter acts synergistically with conventional fungicides to improve plant health and vigor, increasing yields by up to seven bushels per acre in soybeans and 13 bushels per acre in corn, the company said in a statement. Newgioco Group Inc (NASDAQ:NWGI) said Tuesday that it kicked off esports wagering last week through its online betting channel in Italy and it will embrace League of Legends, DOTA, Starcraft, as well as esports versions of NBA Basketball, Formula One and MotoGP. In a statement, the Toronto-based global sports betting and gaming technology company, said that esports wagering took off on April 3. ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) announced the design Tuesday of a new high-strength, cost-effective aluminium chassis for its signature single-seat SOLO electric vehicle. The aluminium chassis — the vehicle’s metal skeletal framework — will replace the company’s current composite version in the SOLO EV, making it better suited for mass production by reducing both its weight and per-unit assembly cost.  Calyxt Inc (NASDAQ:CLXT) has licensed a unique technology designed to boost efficiency in gene-edited plants, it said on Tuesday. The method, developed by the University of Minnesota, potentially reduces the time needed to edit plants to a matter of months rather than years. The Roseville, Minnesota-based company said that the new technology could increase the speed at which highly desired products like better-tasting plant proteins reach consumers faster. Global Energy Metals Corporation (CVE:GEMC) (OTCMKTS:GBLEF) told investors it has struck a renegotiated deal over its high-grade cobalt projects in Nevada, USA, which will give it a controlling interest earlier than planned. The new deal with Nevada Sunrise and Primus Resources will replace and supersede the original option agreement of January last year, in which Global Energy Metals had an option to purchase an undivided 85% interest in the Lovelock and Treasure Box battery minerals project. Power Ore Inc (CVE:PORE) told shareholders Tuesday that it is committed to delivering a technical report on its newly acquired Robitaille and Cooke properties in Quebec as quickly as possible. The February acquisition boosted the company’s flagship Opemiska Copper Complex property from 797 hectares to 9,852 hectares. However, the report may be delayed due to the unprecedented shutdown of businesses and free movement in light of the coronavirus (COVID-19) pandemic, the company acknowledged. Q BioMed Inc (OTCQB:QBIO), which has developed cancer bone pain drug Strontium89, announced Tuesday that it has launched a financial restructuring plan. Under the plan, the company’s lead investor Yorkville Advisors Global (YA) will convert a minimum of $3.8 million into common stock and preferred stock and may convert an additional $500,000, which would be the total debt held by them.  And as part of the agreement, which has yet to close, YA will fund an additional $4 million in new capital over the next 2 weeks, according to a statement. OTC Markets Group Inc (OTCQX:OTCM) has enhanced the bank call report data available on OTCMarkets.com by including interactive historical data trend charts for the more than 550 US community banks trading on the OTCQX, OTCQB and Pink markets. Bank call reports come with a slew of data, and the sheer volume of it can make pinpointing changes over time difficult, the group said. The OTC’s new interactive data tools allow users to seamlessly evaluate trends without having to download multiple individual reports and create their own spreadsheets. Lithoquest Diamonds Inc (CVE:LDI) has said it is extending a previously announced private placing, having received the go-ahead from the Toronto Venture Exchange. On February 20, the firm announced the financing for up to $250,000 priced at $0.03 a share to be used for general working capital. Valens GroWorks Corp (CVE:VLNS) (OTCQX:VLNCF), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, announced that it will issue its first-quarter financial results, for the period ended February 29, 2020, on Tuesday, April 14, 2020, after the markets close. The company also said it will host a conference call the following day, Wednesday, April 15, 2020, at 11.00am Eastern Time/8.00am Pacific Time to discuss the financial results and business outlook. Participant Dial-In Numbers are: Toll-Free: 1-877-407-0792; Toll/International: 1-201-689-8263. Participants should request The Valens Company Earnings Call or provide confirmation code 13701091.